Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Vaccines Through Centuries: Major Cornerstones of Global Health.

Hajj Hussein I, Chams N, Chams S, El Sayegh S, Badran R, Raad M, Gerges-Geagea A, Leone A, Jurjus A.

Front Public Health. 2015 Nov 26;3:269. doi: 10.3389/fpubh.2015.00269. eCollection 2015. Review.

2.

Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design.

Zhen SS, Li Y, Wang SM, Zhang XJ, Hao ZY, Chen Y, Wang D, Zhang YH, Zhang ZY, Ma JC, Zhou P, Zhang Z, Jiang ZW, Zhao YL, Wang XY.

Emerg Microbes Infect. 2015 Oct;4(10):e64. doi: 10.1038/emi.2015.64. Epub 2015 Oct 28.

3.

Methodological challenges in measuring vaccine effectiveness using population cohorts in low resource settings.

King C, Beard J, Crampin AC, Costello A, Mwansambo C, Cunliffe NA, Heyderman RS, French N, Bar-Zeev N; VacSurv Consortium.

Vaccine. 2015 Sep 11;33(38):4748-55. doi: 10.1016/j.vaccine.2015.07.062. Epub 2015 Jul 30. Review.

4.

Seasonal influenza vaccination for children in Thailand: a cost-effectiveness analysis.

Meeyai A, Praditsitthikorn N, Kotirum S, Kulpeng W, Putthasri W, Cooper BS, Teerawattananon Y.

PLoS Med. 2015 May 26;12(5):e1001829; discussion e1001829. doi: 10.1371/journal.pmed.1001829. eCollection 2015 May.

5.

Veterinary and human vaccine evaluation methods.

Knight-Jones TJ, Edmond K, Gubbins S, Paton DJ.

Proc Biol Sci. 2014 Apr 16;281(1784):20132839. doi: 10.1098/rspb.2013.2839. Print 2014 Jun 7. Review.

6.

Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions.

Deen J, Ali M, Sack D.

PLoS One. 2014 Feb 7;9(2):e88139. doi: 10.1371/journal.pone.0088139. eCollection 2014.

7.

Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines.

Fowkes FJ, Simpson JA, Beeson JG.

BMC Med. 2013 Oct 30;11:232. doi: 10.1186/1741-7015-11-232.

8.

Effectiveness of one dose of mumps vaccine against clinically diagnosed mumps in Guangzhou, China, 2006-2012.

Fu C, Xu J, Cai Y, He Q, Zhang C, Chen J, Dong Z, Hu W, Wang H, Zhu W, Wang M.

Hum Vaccin Immunother. 2013 Dec;9(12):2524-8. doi: 10.4161/hv.26113. Epub 2013 Aug 16.

9.

Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials.

Griffiths UK, Clark A, Gessner B, Miners A, Sanderson C, Sedyaningsih ER, Mulholland KE.

Epidemiol Infect. 2012 Aug;140(8):1343-55. doi: 10.1017/S0950268812000957. Epub 2012 May 14. Review.

10.

Seasonal influenza vaccine effectiveness among children aged 6 to 59 months in southern China.

Yang Z, Dong Z, Fu C.

PLoS One. 2012;7(1):e30424. doi: 10.1371/journal.pone.0030424. Epub 2012 Jan 24.

11.

Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countries.

Clemens J.

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2799-805. doi: 10.1098/rstb.2011.0033. Review.

12.

Matched case-control study of effectiveness of live, attenuated S79 mumps virus vaccine against clinical mumps.

Fu C, Liang J, Wang M.

Clin Vaccine Immunol. 2008 Sep;15(9):1425-8. doi: 10.1128/CVI.00122-08. Epub 2008 Jul 30.

13.

BCG revaccination does not protect against leprosy in the Brazilian Amazon: a cluster randomised trial.

Cunha SS, Alexander N, Barreto ML, Pereira ES, Dourado I, Maroja Mde F, Ichihara Y, Brito S, Pereira S, Rodrigues LC.

PLoS Negl Trop Dis. 2008 Feb 13;2(2):e167. doi: 10.1371/journal.pntd.0000167.

14.

Endpoints and regulatory issues in HIV vaccine clinical trials: lessons from a workshop.

Follmann D, Duerr A, Tabet S, Gilbert P, Moodie Z, Fast P, Cardinali M, Self S.

J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):49-60.

15.

Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.

Hak E, Verheij TJ, Grobbee DE, Nichol KL, Hoes AW.

J Epidemiol Community Health. 2002 Dec;56(12):951-5. Review.

16.

The WHO Global Programme for Vaccines and Immunization Vaccine Trial Registry.

Robertson SE, Mayans MV, Horsfall S, Wright PF, Clemens J, Ivanoff B, Lambert PH.

Bull World Health Organ. 1997;75(4):295-305.

17.

A global theme issue: bibliography of references.

Winker MA.

Emerg Infect Dis. 1996 Oct-Dec;2(4):365-72. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk